Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance.
about
Development of multigene expression signature maps at the protein level from digitized immunohistochemistry slidesFlow cytometric analysis of estrogen receptor expression in isolated nuclei and cells from mammary cancer tissues.Can 18F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with 18F-Fluorodeoxyglucose Positron Emission Tomography?Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcomeImmunocompetent mouse allograft models for development of therapies to target breast cancer metastasis.Significance of immunohistochemistry in breast cancerEstrogen and progesterone receptors in cytology: a comprehensive review.Frequency of oestrogen and progesterone receptor positivity by immunohistochemical analysis in 7016 breast carcinomas: correlation with patient age, assay sensitivity, threshold value, and mammographic screening.TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.Prognostic factors. Stage and receptor status in breast cancer.Prognostic factors for breast cancer and their use in the clinical setting.Comparing computer-generated and pathologist-generated tumour segmentations for immunohistochemical scoring of breast tissue microarrays.Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancerAnalysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor-Positive, HER2-Negative Early Breast Cancer.Analysis of prognostic factors and treatment modality changes in breast cancer: a single institution study in KoreaOestrogen receptor analysis: correlation between enzyme immunoassay and immunohistochemical methods.A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors.Immunohistochemical analysis of estrogen receptors in prostate and clinical correlation in men with benign prostatic hyperplasia.Estrogen and progesterone receptors in breast cancer.Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned.Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridization analysis of micro-RNA expression in arrays of archival tumour tissue.Androgen and vitamin D receptor expression in archival human breast tumors.Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.Immunoperoxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval.Abnormal expression of four novel molecular markers represents a highly aggressive phenotype in breast cancer. Immunohistochemical assay of p53, nm23, erbB-2, and cathepsin D protein.Phosphorylated S6K1 is a possible marker for endocrine therapy resistance in hormone receptor-positive breast cancer.Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables.A predictive model for the development of hormone-responsive breast cancer.Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network StudyDetermination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases.Role of IGFs and insulin in the human testis during postnatal activation: differentiation of steroidogenic cells.Different clinical impact of estradiol receptor determination according to the analytical method: A study on 1940 breast cancer patients over a period of 16 consecutive years.Expression of steroid receptors in intact rat uterus, mammary gland, and liver treated with selective estrogen receptor modulators and conjugated equine estrogens.Role of oestrogen receptor-α and -β in bladder tissue of patients with a clinical diagnosis of benign prostatic hyperplasia.CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.Expression of aromatase, estrogen receptor alpha and beta, androgen receptor, and cytochrome P-450scc in the human early prepubertal testis.Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders.
P2860
Q28731283-25B1ED2F-15C3-4E6A-BE7D-F78361DDA1D2Q30809810-17049284-4E4D-4827-B3E4-1D536C561891Q33702526-EDF37EC7-E6AE-4881-8040-3B98F8665972Q33745113-35A42F2A-568B-4F72-814C-271F827F5D53Q33761491-6ACF30D8-5DFA-46B2-8510-EF9BBC4C2FF5Q34023682-1F6E308B-811C-47C9-8203-8D7CD484ECD4Q35374145-FABE7941-B7FC-40B7-AC8A-BCED34E5B593Q35396974-58369142-D91D-4CD7-8010-B54A0AD21D3EQ35651935-7CA0569E-5396-4CA9-AC2D-49C8DB63E67DQ35749359-BEB19631-C970-4AF1-A977-A7ACE12D47C9Q35782175-1F75F156-132A-46EC-AD8A-0D8D33F4B84BQ36118398-04A70252-2480-4F7B-8A55-62F74C531316Q36295039-181B8B0C-28C8-4A4F-BBCC-ADE25F00E668Q36615792-32F70609-2EA6-4BAB-849A-ED7CE9B697D2Q36804506-0532CE95-FA9B-41C1-9A5D-25FC6BE0E42DQ37065467-C8DA0CC3-64E8-4656-985E-A4999F012AC2Q37116022-E4831C09-41CA-4790-AD36-229F00E55F5FQ37596035-4BBB1756-557E-49DC-8792-5507CAC1C38EQ37671693-EF3B6D74-C12D-48FF-83BA-BE97597D16F3Q38282467-7493070F-A923-4823-8350-DFA096ADA7EAQ38379915-C0789580-B194-44F0-9774-A9F1043AC497Q38405561-B2EFBABA-90AC-4565-B4F8-C3F7E0599F93Q38448708-47861C3B-219E-434D-B317-A52E41C7A0E3Q38449877-4DAF3806-E3C2-4E83-B39B-7B27900FF15CQ38472955-62678428-5D79-450C-9CE1-950E66E1FF44Q38474705-D3A0EE6A-C36D-4BF9-83FF-B09D40775420Q38478590-BAD15A53-3E43-447B-BA29-D1AFFDF35D5BQ38504589-6F961281-A8A0-48A6-B55C-E71351D699A1Q40430925-7B7C541B-D328-4571-BE7D-991EA423459EQ40773847-15803205-FED6-4B5B-86AB-4D42E067EE10Q45237144-2D7654F9-46A8-4F55-A3D1-1C3309D9AE6EQ45942230-C5810CFC-5619-4866-90F9-7AE2A0DB6137Q46562142-3ABB70BA-EC23-448D-AB83-FF6A4D4A2FF5Q46827610-344B94AA-7F3F-4484-B973-53780B2EA823Q46970671-2AF18247-E2EB-4F21-807C-A9A646072407Q48301807-FF4908F8-A5D6-485B-8AF6-73FB8DB67A8CQ52665317-196BE685-E33B-48DA-B12D-FD12F93933F6Q53591414-C0313EA2-7933-4AA2-99BD-B67CFD3B05E0Q55224577-4DA72890-57AE-4DAF-AC3E-9FC5F725B096
P2860
Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance.
description
1990 nî lūn-bûn
@nan
1990 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Immunocytochemical analysis of ...... assay and clinical relevance.
@ast
Immunocytochemical analysis of ...... assay and clinical relevance.
@en
type
label
Immunocytochemical analysis of ...... assay and clinical relevance.
@ast
Immunocytochemical analysis of ...... assay and clinical relevance.
@en
prefLabel
Immunocytochemical analysis of ...... assay and clinical relevance.
@ast
Immunocytochemical analysis of ...... assay and clinical relevance.
@en
P2093
P1433
P1476
Immunocytochemical analysis of ...... assay and clinical relevance.
@en
P2093
C O Daniel
D C Allred
H V Gaskill
M A Bustamante
P304
P356
10.1001/ARCHSURG.1990.01410130113018
P577
1990-01-01T00:00:00Z